<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38988667</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Inflammaging, immunosenescence, and cardiovascular aging: insights into long COVID implications.</ArticleTitle><Pagination><StartPage>1384996</StartPage><MedlinePgn>1384996</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1384996</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2024.1384996</ELocationID><Abstract><AbstractText>Aging leads to physiological changes, including inflammaging-a chronic low-grade inflammatory state with significant implications for various physiological systems, particularly for cardiovascular health. Concurrently, immunosenescence-the age-related decline in immune function, exacerbates vulnerabilities to cardiovascular pathologies in older individuals. Examining the dynamic connections between immunosenescence, inflammation, and cardiovascular aging, this mini-review aims to disentangle some of these interactions for a better understanding of their complex interplay. In the context of cardiovascular aging, the chronic inflammatory state associated with inflammaging compromises vascular integrity and function, contributing to atherosclerosis, endothelial dysfunction, arterial stiffening, and hypertension. The aging immune system's decline amplifies oxidative stress, fostering an environment conducive to atherosclerotic plaque formation. Noteworthy inflammatory markers, such as the high-sensitivity C-reactive protein, interleukin-6, interleukin-1&#x3b2;, interleukin-18, and tumor necrosis factor-alpha emerge as key players in cardiovascular aging, triggering inflammatory signaling pathways and intensifying inflammaging and immunosenescence. In this review we aim to explore the molecular and cellular mechanisms underlying inflammaging and immunosenescence, shedding light on their nuanced contributions to cardiovascular diseases. Furthermore, we explore the reciprocal relationship between immunosenescence and inflammaging, revealing a self-reinforcing cycle that intensifies cardiovascular risks. This understanding opens avenues for potential therapeutic targets to break this cycle and mitigate cardiovascular dysfunction in aging individuals. Furthermore, we address the implications of Long COVID, introducing an additional layer of complexity to the relationship between aging, immunosenescence, inflammaging, and cardiovascular health. Our review aims to stimulate continued exploration and advance our understanding within the realm of aging and cardiovascular health.</AbstractText><CopyrightInformation>&#xa9; 2024 M&#xfc;ller and Di Benedetto.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Ludmila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Benedetto</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">aging</Keyword><Keyword MajorTopicYN="N">cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">immunosenescence</Keyword><Keyword MajorTopicYN="N">inflammaging</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>11</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38988667</ArticleId><ArticleId IdType="pmc">PMC11233824</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2024.1384996</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pawelec G. Age and immunity: what is &#x201c;immunosenescence&#x201d;? Exp Gerontol. (2018) 105:4&#x2013;9. 10.1016/j.exger.2017.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.10.024</ArticleId><ArticleId IdType="pubmed">29111233</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J. The twilight of immunity: emerging concepts in aging of the immune system. Nat Immunol. (2018) 19(1):10&#x2013;9. 10.1038/s41590-017-0006-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-017-0006-x</ArticleId><ArticleId IdType="pubmed">29242543</ArticleId></ArticleIdList></Reference><Reference><Citation>Pangrazzi L, Weinberger B. T cells, aging and senescence. Exp Gerontol. (2020) 134:110887. 10.1016/j.exger.2020.110887</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2020.110887</ArticleId><ArticleId IdType="pubmed">32092501</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. (2000) 908:244&#x2013;54. 10.1111/j.1749-6632.2000.tb06651.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto S, M&#xfc;ller L, Wenger E, Duzel S, Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci Biobehav Rev. (2017) 75:114&#x2013;28. 10.1016/j.neubiorev.2017.01.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.01.044</ArticleId><ArticleId IdType="pubmed">28161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberale L, Montecucco F, Tardif JC, Libby P, Camici GG. Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. Eur Heart J. (2020) 41(31):2974&#x2013;82. 10.1093/eurheartj/ehz961</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz961</ArticleId><ArticleId IdType="pmc">PMC7453832</ArticleId><ArticleId IdType="pubmed">32006431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. (2018) 15(9):505&#x2013;22. 10.1038/s41569-018-0064-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L, Fulop T, Pawelec G. Immunosenescence in vertebrates and invertebrates. Immun Ageing. (2013) 10(1):12. 10.1186/1742-4933-10-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-10-12</ArticleId><ArticleId IdType="pmc">PMC3637519</ArticleId><ArticleId IdType="pubmed">23547999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev. (2005) 205:257&#x2013;68. 10.1111/j.0105-2896.2005.00271.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00271.x</ArticleId><ArticleId IdType="pubmed">15882359</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L, Di Benedetto S, Pawelec G. The immune system and its dysregulation with aging. Subcell Biochem. (2019) 91:21&#x2013;43. 10.1007/978-981-13-3681-2_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-3681-2_2</ArticleId><ArticleId IdType="pubmed">30888648</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu W, Rao S. Mechanisms underlying T cell immunosenescence: aging and cytomegalovirus infection. Front Microbiol. (2016) 7:2111. 10.3389/fmicb.2016.02111</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.02111</ArticleId><ArticleId IdType="pmc">PMC5186782</ArticleId><ArticleId IdType="pubmed">28082969</ArticleId></ArticleIdList></Reference><Reference><Citation>Barcena ML, Aslam M, Pozdniakova S, Norman K, Ladilov Y. Cardiovascular inflammaging: mechanisms and translational aspects. Cells. (2022) 11(6). 10.3390/cells11061010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11061010</ArticleId><ArticleId IdType="pmc">PMC8946971</ArticleId><ArticleId IdType="pubmed">35326461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajoolabady A, Pratico D, Vinciguerra M, Lip GYH, Franceschi C, Ren J. Inflammaging: mechanisms and role in the cardiac and vasculature. Trends Endocrinol Metab. (2023) 34(6):373&#x2013;87. 10.1016/j.tem.2023.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.005</ArticleId><ArticleId IdType="pubmed">37076375</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. (2021) 18(9):666&#x2013;82. 10.1038/s41569-021-00552-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00552-1</ArticleId><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>Keegan PM, Wilder CL, Platt MO. Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte&#x2013;endothelial cell signaling and JNK activation. Mol Cell Biochem. (2012) 367(1):65&#x2013;72. 10.1007/s11010-012-1320-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-012-1320-0</ArticleId><ArticleId IdType="pmc">PMC3390414</ArticleId><ArticleId IdType="pubmed">22562303</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumori A. Nuclear factor-kappaB is a prime candidate for the diagnosis and control of inflammatory cardiovascular disease. Eur Cardiol. (2023) 18:e40. 10.15420/ecr.2023.10</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2023.10</ArticleId><ArticleId IdType="pmc">PMC10345985</ArticleId><ArticleId IdType="pubmed">37456770</ArticleId></ArticleIdList></Reference><Reference><Citation>Papaconstantinou J. The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease. Cells. (2019) 8(11). 10.3390/cells8111383</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8111383</ArticleId><ArticleId IdType="pmc">PMC6912541</ArticleId><ArticleId IdType="pubmed">31689891</ArticleId></ArticleIdList></Reference><Reference><Citation>Reustle A, Torzewski M. Role of p38 MAPK in atherosclerosis and aortic valve sclerosis. Int J Mol Sci. (2018) 19(12). 10.3390/ijms19123761</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123761</ArticleId><ArticleId IdType="pmc">PMC6321637</ArticleId><ArticleId IdType="pubmed">30486366</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Heiden K, Cuhlmann S, Luong le A, Zakkar M, Evans PC. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond). (2010) 118(10):593&#x2013;605. 10.1042/CS20090557</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20090557</ArticleId><ArticleId IdType="pubmed">20175746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavenier J, Rasmussen LJH, Houlind MB, Andersen AL, Panum I, Andersen O, et al. Alterations of monocyte NF-kappaB p65/RelA signaling in a cohort of older medical patients, age-matched controls, and healthy young adults. Immun Ageing. (2020) 17(1):25. 10.1186/s12979-020-00197-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-00197-7</ArticleId><ArticleId IdType="pmc">PMC7938715</ArticleId><ArticleId IdType="pubmed">33685482</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal GM, Wahlstrom JS, Crawley CD, Cahill KE, Pytel P, Liang H, et al. Loss of Nfkb1 leads to early onset aging. Aging (Albany NY. (2014) 6(11):931&#x2013;43. 10.18632/aging.100702</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100702</ArticleId><ArticleId IdType="pmc">PMC4276787</ArticleId><ArticleId IdType="pubmed">25553648</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Garcia VA, Alameda JP, Page A, Casanova ML. Role of NF-kappaB in ageing and age-related diseases: lessons from genetically modified mouse models. Cells. (2021) 10(8). 10.3390/cells10081906</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081906</ArticleId><ArticleId IdType="pmc">PMC8394846</ArticleId><ArticleId IdType="pubmed">34440675</ArticleId></ArticleIdList></Reference><Reference><Citation>Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. (2013) 18(4):519&#x2013;32. 10.1016/j.cmet.2013.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.09.010</ArticleId><ArticleId IdType="pmc">PMC4017327</ArticleId><ArticleId IdType="pubmed">24093676</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang R, Qi X, Cai Q, Niu L, Huang X, Zhang D, et al. The role of NLRP3 inflammasome in aging and age-related diseases. Immun Ageing. (2024) 21(1):14. 10.1186/s12979-023-00395-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-023-00395-z</ArticleId><ArticleId IdType="pmc">PMC10840156</ArticleId><ArticleId IdType="pubmed">38317229</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao LZ, Chen ZC, Wang SS, Liu WB, Zhao CL, Zhuang XD. NLRP3 inflammasome activation contributes to the pathogenesis of cardiocytes aging. Aging (Albany NY. (2021) 13(16):20534&#x2013;51. 10.18632/aging.203435</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203435</ArticleId><ArticleId IdType="pmc">PMC8436929</ArticleId><ArticleId IdType="pubmed">34432650</ArticleId></ArticleIdList></Reference><Reference><Citation>de Arellano ML B, Pozdniakova S, Kuhl AA, Baczko I, Ladilov Y, Regitz-Zagrosek V. Sex differences in the aging human heart: decreased sirtuins, pro-inflammatory shift and reduced anti-oxidative defense. Aging (Albany NY). (2019) 11(7):1918&#x2013;33. 10.18632/aging.101881</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101881</ArticleId><ArticleId IdType="pmc">PMC6503880</ArticleId><ArticleId IdType="pubmed">30964749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Kroemer G, Kepp O. Mitophagy: an emerging role in aging and age-associated diseases. Front Cell Dev Biol. (2020) 8:200. 10.3389/fcell.2020.00200</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00200</ArticleId><ArticleId IdType="pmc">PMC7113588</ArticleId><ArticleId IdType="pubmed">32274386</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinti M, Cevenini E, Nasi M, De Biasi S, Salvioli S, Monti D, et al. Circulating mitochondrial DNA increases with age and is a familiar trait: implications for &#x201c;inflamm-aging&#x201d;. Eur J Immunol. (2014) 44(5):1552&#x2013;62. 10.1002/eji.201343921</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201343921</ArticleId><ArticleId IdType="pubmed">24470107</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz CS D, Kang MJ. Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion. (2018) 41:37&#x2013;44. 10.1016/j.mito.2017.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2017.12.001</ArticleId><ArticleId IdType="pmc">PMC5988941</ArticleId><ArticleId IdType="pubmed">29221810</ArticleId></ArticleIdList></Reference><Reference><Citation>Sverdlov AL, Ngo DT, Chan WP, Chirkov YY, Horowitz JD. Aging of the nitric oxide system: are we as old as our NO? J Am Heart Assoc. (2014) 3(4). 10.1161/JAHA.114.000973</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.000973</ArticleId><ArticleId IdType="pmc">PMC4310385</ArticleId><ArticleId IdType="pubmed">25134680</ArticleId></ArticleIdList></Reference><Reference><Citation>Swastini DA, Wiryanthini IAD, Ariastuti NLP, Muliantara A. Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia. Open Access Maced J Med Sci. (2019) 7(22):3887&#x2013;90. 10.3889/oamjms.2019.526</Citation><ArticleIdList><ArticleId IdType="doi">10.3889/oamjms.2019.526</ArticleId><ArticleId IdType="pmc">PMC7048367</ArticleId><ArticleId IdType="pubmed">32127998</ArticleId></ArticleIdList></Reference><Reference><Citation>Puspitasari YM, Ministrini S, Schwarz L, Karch C, Liberale L, Camici GG. Modern concepts in cardiovascular disease: inflamm-aging. Front Cell Dev Biol. (2022) 10:882211. 10.3389/fcell.2022.882211</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.882211</ArticleId><ArticleId IdType="pmc">PMC9158480</ArticleId><ArticleId IdType="pubmed">35663390</ArticleId></ArticleIdList></Reference><Reference><Citation>Du W, Wong C, Song Y, Shen H, Mori D, Rotllan N, et al. Age-associated vascular inflammation promotes monocytosis during atherogenesis. Aging Cell. (2016) 15(4):766&#x2013;77. 10.1111/acel.12488</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12488</ArticleId><ArticleId IdType="pmc">PMC4933655</ArticleId><ArticleId IdType="pubmed">27135421</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. (2017) 70(4):660&#x2013;7. 10.1161/HYPERTENSIONAHA.117.07802</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.07802</ArticleId><ArticleId IdType="pubmed">28784646</ArticleId></ArticleIdList></Reference><Reference><Citation>Cederstr&#xf6;m S, Lundman P, Alfredsson J, Hagstr&#xf6;m E, Ravn-Fischer A, S&#xf6;derberg S, et al. Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population. Sci Rep. (2023) 13(1):12171. 10.1038/s41598-023-39051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39051-3</ArticleId><ArticleId IdType="pmc">PMC10374905</ArticleId><ArticleId IdType="pubmed">37500663</ArticleId></ArticleIdList></Reference><Reference><Citation>Banait T, Wanjari A, Danade V, Banait S, Jain J. Role of high-sensitivity C-reactive protein (hs-CRP) in non-communicable diseases: a review. Cureus. (2022) 14(10):e30225. 10.7759/cureus.30225</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.30225</ArticleId><ArticleId IdType="pmc">PMC9650935</ArticleId><ArticleId IdType="pubmed">36381804</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. (2019) 10:2247. 10.3389/fimmu.2019.02247</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02247</ArticleId><ArticleId IdType="pmc">PMC6773825</ArticleId><ArticleId IdType="pubmed">31608061</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang L, et al. Immunosenescence: molecular mechanisms and diseases. Signal Transduction and Targeted Therapy. (2023) 8(1):200. 10.1038/s41392-023-01451-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01451-2</ArticleId><ArticleId IdType="pmc">PMC10182360</ArticleId><ArticleId IdType="pubmed">37179335</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousif LI, Tanja AA, de Boer RA, Teske AJ, Meijers WC. The role of immune checkpoints in cardiovascular disease. Front Pharmacol. (2022) 13:989431. 10.3389/fphar.2022.989431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.989431</ArticleId><ArticleId IdType="pmc">PMC9574006</ArticleId><ArticleId IdType="pubmed">36263134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha LL, Perazzio SF, Azzi J, Cravedi P, Riella LV. Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response. Front Immunol. (2020) 11:1748. 10.3389/fimmu.2020.01748</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01748</ArticleId><ArticleId IdType="pmc">PMC7427491</ArticleId><ArticleId IdType="pubmed">32849623</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves AS, Bueno V. Immunosenescence: participation of T lymphocytes and myeloid-derived suppressor cells in aging-related immune response changes. Einstein (Sao Paulo. (2019) 17(2):eRB4733. 10.31744/einstein_journal/2019RB4733</Citation><ArticleIdList><ArticleId IdType="doi">10.31744/einstein_journal/2019RB4733</ArticleId><ArticleId IdType="pmc">PMC6497120</ArticleId><ArticleId IdType="pubmed">31066797</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons KH, de Jong A, Jukema JW, de Vries MR, Arens R, Quax PHA. T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword. Nat Rev Cardiol. (2019) 16(6):325&#x2013;43. 10.1038/s41569-019-0164-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0164-7</ArticleId><ArticleId IdType="pubmed">30770894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallat Z, Binder CJ. The why and how of adaptive immune responses in ischemic cardiovascular disease. Nat Cardiovasc Res. (2022) 1:431&#x2013;44. 10.1038/s44161-022-00049-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-022-00049-1</ArticleId><ArticleId IdType="pmc">PMC7613798</ArticleId><ArticleId IdType="pubmed">36382200</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira BI, Akbar AN. Convergence of innate and adaptive immunity during human aging. Front Immunol. (2016) 7:445. 10.3389/fimmu.2016.00445</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00445</ArticleId><ArticleId IdType="pmc">PMC5095488</ArticleId><ArticleId IdType="pubmed">27867379</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R, Wang W, Su DM. Contributions of age-related thymic involution to immunosenescence and inflammaging. Immun Ageing. (2020) 17:2. 10.1186/s12979-020-0173-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-020-0173-8</ArticleId><ArticleId IdType="pmc">PMC6971920</ArticleId><ArticleId IdType="pubmed">31988649</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Geiger H, Rudolph KL. Immunoaging induced by hematopoietic stem cell aging. Curr Opin Immunol. (2011) 23(4):532&#x2013;6. 10.1016/j.coi.2011.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2011.05.004</ArticleId><ArticleId IdType="pubmed">21872769</ArticleId></ArticleIdList></Reference><Reference><Citation>Aw D, Palmer DB. The origin and implication of thymic involution. Aging Dis. (2011) 2(5):437&#x2013;43. PMID: . PMCID: .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3295077</ArticleId><ArticleId IdType="pubmed">22396892</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int. (2009) 22(11):1041&#x2013;50. 10.1111/j.1432-2277.2009.00927.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-2277.2009.00927.x</ArticleId><ArticleId IdType="pubmed">19624493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Weyand CM, Goronzy JJ. Hallmarks of the aging T-cell system. FEBS J. (2021) 288(24). 10.1111/febs.15770</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15770</ArticleId><ArticleId IdType="pmc">PMC8364928</ArticleId><ArticleId IdType="pubmed">33590946</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Q, Liu Y, Cheng Y, Glanville J, Zhang D, Lee JY, et al. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A. (2014) 111(36):13139&#x2013;44. 10.1073/pnas.1409155111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1409155111</ArticleId><ArticleId IdType="pmc">PMC4246948</ArticleId><ArticleId IdType="pubmed">25157137</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Benedetto S, Derhovanessian E, Steinhagen-Thiessen E, Goldeck D, Muller L, Pawelec G. Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II study. Biogerontology. (2015) 16(5):631&#x2013;43. 10.1007/s10522-015-9563-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-015-9563-2</ArticleId><ArticleId IdType="pubmed">25732234</ArticleId></ArticleIdList></Reference><Reference><Citation>de Punder K, Heim C, Wadhwa PD, Entringer S. Stress and immunosenescence: the role of telomerase. Psychoneuroendocrinology. (2019) 101:87&#x2013;100. 10.1016/j.psyneuen.2018.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2018.10.019</ArticleId><ArticleId IdType="pmc">PMC6458519</ArticleId><ArticleId IdType="pubmed">30445409</ArticleId></ArticleIdList></Reference><Reference><Citation>Goronzy JJ, Li G, Yang Z, Weyand CM. The Janus head of T cell aging - autoimmunity and immunodeficiency. Front Immunol. (2013) 4:131. 10.3389/fimmu.2013.00131</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00131</ArticleId><ArticleId IdType="pmc">PMC3671290</ArticleId><ArticleId IdType="pubmed">23761790</ArticleId></ArticleIdList></Reference><Reference><Citation>Mold JE, Reu P, Olin A, Bernard S, Michaelsson J, Rane S, et al. Cell generation dynamics underlying naive T-cell homeostasis in adult humans. PLoS Biol. (2019) 17(10):e3000383. 10.1371/journal.pbio.3000383</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3000383</ArticleId><ArticleId IdType="pmc">PMC6818757</ArticleId><ArticleId IdType="pubmed">31661488</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgobo M, Heinrichs M, Hapke N, Ashour D, Appel M, Srivastava M, et al. Terminally differentiated CD4(+) T cells promote myocardial inflammaging. Front Immunol. (2021) 12:584538. 10.3389/fimmu.2021.584538</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.584538</ArticleId><ArticleId IdType="pmc">PMC7935504</ArticleId><ArticleId IdType="pubmed">33679735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochain C, Zernecke A. Protective and pathogenic roles of CD8(+) T cells in atherosclerosis. Basic Res Cardiol. (2016) 111(6):71. 10.1007/s00395-016-0589-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-016-0589-7</ArticleId><ArticleId IdType="pubmed">27783202</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadley I, Pera A, Morrow G, Davies KA, Kern F. Expansions of cytotoxic CD4(+)CD28(-) T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection. Front Immunol. (2017) 8:195. 10.3389/fimmu.2017.00195</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00195</ArticleId><ArticleId IdType="pmc">PMC5332470</ArticleId><ArticleId IdType="pubmed">28303136</ArticleId></ArticleIdList></Reference><Reference><Citation>Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol. (2020) 17(7):387&#x2013;401. 10.1038/s41569-020-0352-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0352-5</ArticleId><ArticleId IdType="pmc">PMC7872210</ArticleId><ArticleId IdType="pubmed">32203286</ArticleId></ArticleIdList></Reference><Reference><Citation>Laina A, Stellos K, Stamatelopoulos K. Vascular ageing: underlying mechanisms and clinical implications. Exp Gerontol. (2018) 109:16&#x2013;30. 10.1016/j.exger.2017.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2017.06.007</ArticleId><ArticleId IdType="pubmed">28624356</ArticleId></ArticleIdList></Reference><Reference><Citation>Long DA, Newaz MA, Prabhakar SS, Price KL, Truong LD, Feng L, et al. Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney Int. (2005) 68(5):2154&#x2013;63. 10.1111/j.1523-1755.2005.00671.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2005.00671.x</ArticleId><ArticleId IdType="pubmed">16221214</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchie A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. (2021) 21(5):319&#x2013;29. 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Jacobowitz DM, Barone F, McCarron R, Spatz M, Feuerstein G, et al. Quantitation of perivascular monocytes and macrophages around cerebral blood vessels of hypertensive and aged rats. J Cereb Blood Flow Metab. (1994) 14(2):348&#x2013;52. 10.1038/jcbfm.1994.43</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.1994.43</ArticleId><ArticleId IdType="pubmed">8113330</ArticleId></ArticleIdList></Reference><Reference><Citation>Desdin-Mico G, Soto-Heredero G, Aranda JF, Oller J, Carrasco E, Gabande-Rodriguez E, et al. T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science. (2020) 368(6497):1371&#x2013;6. 10.1126/science.aax0860</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax0860</ArticleId><ArticleId IdType="pubmed">32439659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieckmann M, Delgobo M, Gaal C, Buchner L, Steinau P, Reshef D, et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. J Clin Invest. (2019) 129(11):4922&#x2013;36. 10.1172/JCI123859</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI123859</ArticleId><ArticleId IdType="pmc">PMC6819128</ArticleId><ArticleId IdType="pubmed">31408441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Mouton AJ, Lindsey ML. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Transl Res. (2018) 191:15&#x2013;28. 10.1016/j.trsl.2017.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2017.10.001</ArticleId><ArticleId IdType="pmc">PMC5846093</ArticleId><ArticleId IdType="pubmed">29106912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. (2009) 53(4):323&#x2013;30. 10.1016/j.jacc.2008.08.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.08.074</ArticleId><ArticleId IdType="pubmed">19161880</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Hoogen P, de Jager SCA, Huibers MMH, Schoneveld AH, Puspitasari YM, Valstar GB, et al. Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure. J Cell Mol Med. (2019) 23(11):7505&#x2013;16. 10.1111/jcmm.14619</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.14619</ArticleId><ArticleId IdType="pmc">PMC6815814</ArticleId><ArticleId IdType="pubmed">31557411</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z, Lu Y, Wei J, Wu J, Yang J, Cai Z. Abdominal aortic aneurysm: roles of inflammatory cells. Front Immunol. (2020) 11:609161. 10.3389/fimmu.2020.609161</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.609161</ArticleId><ArticleId IdType="pmc">PMC7886696</ArticleId><ArticleId IdType="pubmed">33613530</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T, Larbi A, Pawelec G, Khalil A, Cohen AA, Hirokawa K, et al. Immunology of aging: the birth of inflammaging. Clin Rev Allergy Immunol. (2021). 10.1007/s12016-021-08899-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08899-6</ArticleId><ArticleId IdType="pmc">PMC8449217</ArticleId><ArticleId IdType="pubmed">34536213</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspinall R, Lang PO. Interventions to restore appropriate immune function in the elderly. Immun Ageing. (2018) 15:5. 10.1186/s12979-017-0111-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-017-0111-6</ArticleId><ArticleId IdType="pmc">PMC5785902</ArticleId><ArticleId IdType="pubmed">29416551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross JB, Myers LM, Noh JJ, Collins MM, Carmody AB, Messer RJ, et al. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature. (2024) 628(8006):162&#x2013;70. 10.1038/s41586-024-07238-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07238-x</ArticleId><ArticleId IdType="pubmed">38538791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. How to make an old immune system young again. Nature. (2024). 10.1038/d41586-024-00871-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-024-00871-6</ArticleId><ArticleId IdType="pubmed">38538898</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Haque MA, Rahman MA, Hossen F, Reza M, Barua A, et al. A review on measures to rejuvenate immune system: natural mode of protection against coronavirus infection. Front Immunol. (2022) 13:837290. 10.3389/fimmu.2022.837290</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.837290</ArticleId><ArticleId IdType="pmc">PMC8965011</ArticleId><ArticleId IdType="pubmed">35371007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong S, Wang Q, Kao YR, Diaz A, Tasset I, Kaushik S, et al. Chaperone-mediated autophagy sustains haematopoietic stem-cell function. Nature. (2021) 591(7848):117&#x2013;23. 10.1038/s41586-020-03129-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03129-z</ArticleId><ArticleId IdType="pmc">PMC8428053</ArticleId><ArticleId IdType="pubmed">33442062</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Zhou H, Zhu Y, Sun Q, Ji Y, Xue A, et al. Elimination of senescent cells by beta-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res. (2020) 30(7):574&#x2013;89. 10.1038/s41422-020-0314-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0314-9</ArticleId><ArticleId IdType="pmc">PMC7184167</ArticleId><ArticleId IdType="pubmed">32341413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MJ, Miller CM, Shadrach JL, Wagers AJ, Serwold T. Young, proliferative thymic epithelial cells engraft and function in aging thymuses. J Immunol. (2015) 194(10):4784&#x2013;95. 10.4049/jimmunol.1403158</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1403158</ArticleId><ArticleId IdType="pmc">PMC4481326</ArticleId><ArticleId IdType="pubmed">25870244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. (2020) 288(5):518&#x2013;36. 10.1111/joim.13141</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13141</ArticleId><ArticleId IdType="pmc">PMC7405395</ArticleId><ArticleId IdType="pubmed">32686219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenti E, Bianchessi S, Proulx ST, Palano MT, Genovese L, Raccosta L, et al. Therapeutic regeneration of lymphatic and immune cell functions upon lympho-organoid transplantation. Stem Cell Rep. (2019) 12(6):1260&#x2013;8. 10.1016/j.stemcr.2019.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.04.021</ArticleId><ArticleId IdType="pmc">PMC6565831</ArticleId><ArticleId IdType="pubmed">31155505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal. (2011) 14(8):1551&#x2013;85. 10.1089/ars.2010.3228</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3228</ArticleId><ArticleId IdType="pmc">PMC3061194</ArticleId><ArticleId IdType="pubmed">20812785</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgoni S, Kudryashova KS, Burka K, de Magalhaes JP. Targeting immune dysfunction in aging. Ageing Res Rev. (2021) 70:101410. 10.1016/j.arr.2021.101410</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101410</ArticleId><ArticleId IdType="pubmed">34280555</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K, Xie S, Qiu X, Mohrin M, Shin J, Liu Y, et al. SIRT3 reverses aging-associated degeneration. Cell Rep. (2013) 3(2):319&#x2013;27. 10.1016/j.celrep.2013.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.01.005</ArticleId><ArticleId IdType="pmc">PMC3582834</ArticleId><ArticleId IdType="pubmed">23375372</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J, Wang W, Thomas R, Su DM. Thymic rejuvenation via FOXN1-reprogrammed embryonic fibroblasts (FREFs) to counteract age-related inflammation. JCI Insight. (2020) 5(18). 10.1172/jci.insight.140313</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140313</ArticleId><ArticleId IdType="pmc">PMC7526556</ArticleId><ArticleId IdType="pubmed">32790650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharath LP, Agrawal M, McCambridge G, Nicholas DA, Hasturk H, Liu J, et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. (2020) 32(1):44&#x2013;55.e6. 10.1016/j.cmet.2020.04.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.015</ArticleId><ArticleId IdType="pmc">PMC7217133</ArticleId><ArticleId IdType="pubmed">32402267</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreca MM, Alessandro R, Corrado C. Effects of flavonoids on cancer, cardiovascular and neurodegenerative diseases: role of NF-kappaB signaling pathway. Int J Mol Sci. (2023) 24(11). 10.3390/ijms24119236</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24119236</ArticleId><ArticleId IdType="pmc">PMC10252664</ArticleId><ArticleId IdType="pubmed">37298188</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H, Kim DO, Byun JE, Kim WS, Kim MJ, Song HY, et al. Thioredoxin-interacting protein regulates haematopoietic stem cell ageing and rejuvenation by inhibiting p38 kinase activity. Nat Commun. (2016) 7:13674. 10.1038/ncomms13674</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13674</ArticleId><ArticleId IdType="pmc">PMC5155146</ArticleId><ArticleId IdType="pubmed">27929088</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidi N, Geiger H. Rejuvenation of aged hematopoietic stem cells. Semin Hematol. (2017) 54(1):51&#x2013;5. 10.1053/j.seminhematol.2016.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminhematol.2016.10.005</ArticleId><ArticleId IdType="pmc">PMC5244470</ArticleId><ArticleId IdType="pubmed">28088989</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, et al. Long COVID: mechanisms, risk factors and recovery. Exp Physiol. (2023) 108(1):12&#x2013;27. 10.1113/EP090802</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Morrone MC, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, et al. Long COVID: where we stand and challenges ahead. Cell Death Differ. (2022) 29(10):1891&#x2013;900. 10.1038/s41418-022-01052-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Goerlich E, Chung TH, Hong GH, Metkus TS, Gilotra NA, Post WS, et al. Cardiovascular effects of the post-COVID-19 condition. Nature Cardiovascular Research. (2024). 10.1038/s44161-023-00414-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-023-00414-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. (2022) 43(11):1157&#x2013;72. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28(3):583&#x2013;90. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. (2021) 27(4):601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. (2020) 17(9):543&#x2013;58. 10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV, 3rd, et al. COVID-19 and cardiovascular disease: from bench to bedside. Circ Res. (2021) 128(8):1214&#x2013;36. 10.1161/CIRCRESAHA.121.317997</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. (2020) 130(8):3950&#x2013;3. 10.1172/JCI140183</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140183</ArticleId><ArticleId IdType="pmc">PMC7410042</ArticleId><ArticleId IdType="pubmed">32459663</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller L, Di Benedetto S. From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity. Front Immunol. (2023) 14:1298004. 10.3389/fimmu.2023.1298004</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1298004</ArticleId><ArticleId IdType="pmc">PMC10628127</ArticleId><ArticleId IdType="pubmed">37942323</ArticleId></ArticleIdList></Reference><Reference><Citation>Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection. (2022) 50(5):1053&#x2013;66. 10.1007/s15010-022-01835-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01835-6</ArticleId><ArticleId IdType="pmc">PMC9055372</ArticleId><ArticleId IdType="pubmed">35489015</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. (2020) 395(10234):1417&#x2013;8. 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshafei A, Khidr EG, El-Husseiny AA, Gomaa MH. RAAS, ACE2 and COVID-19; a mechanistic review. Saudi J Biol Sci. (2021) 28(11):6465&#x2013;70. 10.1016/j.sjbs.2021.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2021.07.003</ArticleId><ArticleId IdType="pmc">PMC8270731</ArticleId><ArticleId IdType="pubmed">34305426</ArticleId></ArticleIdList></Reference><Reference><Citation>South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. (2020) 318(5):H1084&#x2013;H90. 10.1152/ajpheart.00217.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00217.2020</ArticleId><ArticleId IdType="pmc">PMC7191628</ArticleId><ArticleId IdType="pubmed">32228252</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo RB, Botelho BG, de Hollanda JVG, Ferreira LVL, de Andrade LZJ, Oei SSML, et al. COVID-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. (2021) 35(1):4&#x2013;11. 10.1038/s41371-020-0387-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0387-4</ArticleId><ArticleId IdType="pmc">PMC7384729</ArticleId><ArticleId IdType="pubmed">32719447</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc Natl Acad Sci U S A. (2021) 118(21). 10.1073/pnas.2105968118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua R, Gao H, He C, Xin S, Wang B, Zhang S, et al. An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed. Front Cardiovasc Med. (2023) 10:1273502. 10.3389/fcvm.2023.1273502</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1273502</ArticleId><ArticleId IdType="pmc">PMC10764515</ArticleId><ArticleId IdType="pubmed">38179503</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A, Bozzani A, Tavazzi G, Urtis M, Giuliani L, Pizzoccheri R, et al. Long COVID: long-term effects? Eur Heart J Suppl. (2021) 23(Suppl E):E1&#x2013;5. 10.1093/eurheartj/suab080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab080</ArticleId><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>